Alivus Life Sciences Limited Share Price & Technical Analysis
ALIVUS · ₹1,091 (+3.91%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹1,091
+3.91%
Alivus Life Sciences Limited develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally. It offers various APIs, such as olmesartan, telmisartan, solifenacin, sitagliptin, zonisamide, rosuvastatin, amiodarone, ezetimibe, lithium carbonate, oxcarbazepine, mirabegron, atovaquone, etoricoxib, remogliflozin, cabozantinib,…
Price chart
Seasonality
May has 1 positive and 1 negative years (last 2 years shown)
5% return in May, -5% avg return in past 3 year May month.
24% return in 2026, 4% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 5% | 0% | 10% | 4% | 5% | – | – | – | – | – | – | – | 24% |
| 25 | 19% | -23% | 22% | 2% | -5% | -4% | 3% | -8% | -1% | -1% | -1% | 2% | 4% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Uptrend
Alivus Life Sciences Limited develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally. It offers various APIs, such as olmesartan, telmisartan, solifenacin, sitagliptin, zonisamide, rosuvastatin, amiodarone, ezetimibe, lithium carbonate, oxcarbazepine, mirabegron, atovaquone, etoricoxib, remogliflozin, cabozantinib, and palbociclib for various therapeutic areas, including cardiovascular disease, central nervous system disorders, diabetes, gastrointestinal health, oncology, pain management, immunosuppressant, respiratory and ophthalmologic agents, urology, and anti-infectives. The company also provides contract development and manufacturing services to a range of multinational corporations and specialty companies. It exports its products. The company was formerly known as Glenmark Life Sciences Limited and changed its name to Alivus Life Sciences Limited in December 2024. The company was founded in 2001 and is based in Mumbai, India. Alivus Life Sciences Limited is a subsidiary of Nirma Limited.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹134.86B
P/E ratio
24.83
52W high
₹1,148
52W low
₹819.0
Volume
1,59,360
Beta
0.06
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Alivus Life Sciences Limited share price today?
- Alivus Life Sciences Limited (ALIVUS) last traded around ₹1,091 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ALIVUS have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ALIVUS. Download the app for real-time alerts.
- How can I analyze Alivus Life Sciences Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.